A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor

M Oz, DE Lorke, N Kabbani - Pharmacology & therapeutics, 2021 - Elsevier
The recent emergence of coronavirus disease-2019 (COVID-19) as a global pandemic has
prompted scientists to address an urgent need for defining mechanisms of disease …

Neprilysin is a mediator of alternative renin-angiotensin-system activation in the murine and human kidney

O Domenig, A Manzel, N Grobe, E Königshausen… - Scientific reports, 2016 - nature.com
Cardiovascular and renal pathologies are frequently associated with an activated renin-
angiotensin-system (RAS) and increased levels of its main effector and vasoconstrictor …

Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment

AR Pavan, B Terroni, JL Dos Santos - Nitric Oxide, 2024 - Elsevier
Abstract Sickle Cell Anemia (SCA), is an inherited hemoglobinopathy characterized by the
presence of an abnormal hemoglobin (HbS), being the most prevalent sickle cell disease …

Oleanolic acid modulates the renin-angiotensin system and cardiac natriuretic hormone concomitantly with volume and pressure balance in rats

YM Ahn, YH Choi, JJ Yoon, YJ Lee, KW Cho… - European journal of …, 2017 - Elsevier
Oleanolic acid is known to possess beneficial effects on the regulation of the cardiovascular
homeostasis. However, the exact nature of the role of oleanolic acid on the regulation of …

ATR1 angiotensin II receptor reduces hemoglobin s polymerization, phosphatidylserine exposure, and increases deformability of sickle cell disease erythrocytes

CC Guimarães-Nobre, E Mendonça-Reis… - Cell Biochemistry and …, 2022 - Springer
Abstract Angiotensin II (Ang II) regulates blood volume and stimulates erythropoiesis
through AT1 (ATR1) and AT2 (ATR2) receptors, found in multiple tissues, including …

Reduced blood pressure in sickle cell disease is associated with decreased angiotensin converting enzyme (ACE) activity and is not modulated by ACE inhibition

PL Brito, AF Dos Santos, H Chweih, ME Favero… - Plos one, 2022 - journals.plos.org
Background Sickle cell disease (SCD) incurs vaso-occlusive episodes and organ damage,
including nephropathy. Despite displaying characteristics of vascular dysfunction, SCD …

Low urinary levels of angiotensin‐converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia.

AR Belisário, ÉLM Vieira, JA Almeida… - British Journal of …, 2019 - search.ebscohost.com
The article discusses the clinical trials which have shown that angiotensin-converting
enzyme inhibitors (ACEi) can effectively reduce albuminuria in patients with sickle cell …

Vascular effects of the fetal hemoglobin inducer agent 3-(1, 3-dioxoisoindolin-2-yl) benzyl nitrate

B Terroni, LHO de Moraes, AR Pavan, GJ Rodrigues… - Pharmaceuticals, 2022 - mdpi.com
Vascular endothelium is a protective layer of cells lining the lumen of blood vessels that
plays important roles by releasing factors responsible for controlling the vascular tone …

[HTML][HTML] Hormones Action on Erythrocytes and Signaling Pathways

CC Guimarães-Nobre, E Mendonça-Reis… - The Erythrocyte-A …, 2023 - intechopen.com
Erythrocytes are the most abundant cell type in the human body, although considered as
merely hemoglobin carriers for a long time. Extensive studies on its biochemical pathways …

[HTML][HTML] 镰状细胞疾病肾损害

张志宏, 王金泉 - 新医学, 2017 - xinyixue.cn
镰状细胞疾病(SCD) 是一种由编码血红蛋白多肽的基因发生点突变后引起的遗传病.
患者红细胞内出现病态的血红蛋白S (HbS), 在氧张力低的毛细血管, HbS 形成凝胶结构 …